Article
The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old.
Chest - 1 Feb 2005
Straub Daniel A, Minocchieri Stefan, Moeller Alexander, Hamacher Jürg, Wildhaber Johannes H
Abstract excerpt
OBJECTIVE: The study was undertaken to investigate the influence of once-daily treatment with montelukast (Singulair; MSD; Glattbrugg, Switzerland) on levels of exhaled nitric oxide (eNO) and lung function in preschool children with asthma. METHODS: A total of 30 children (19 girls), 2 to 5 years of age, in whom asthma had been newly diagnosed, who had a positive first-degree family history of asthma and a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
